Skip to main content

Mono Bar

Subsite Title

Publications and Digital Products

Cart

Store Navigation

Share Buttons

Page title

Incorporating Alcohol Pharmacotherapies Into Medical Practice

Main page content

KAP Keys for Clinicians Based on TIP 49
Out of stock for ordering

This manual provides physicians with quick reference information about three FDA-approved medications to help patients achieve abstinence from alcohol: acamprosate, disulfiram, and naltrexone (oral and extended-release). It also includes patient management tips.

Publication ID
SMA10-4544
Publication Date
June 2010

You May Also Be Interested In

Advisory: Prescribing Pharmacotherapies for Patients With Alcohol Use Disorder

This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence.

Incorporating Alcohol Pharmacotherapies Into Medical Practice

This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.

TIP 49: Incorporating Alcohol Pharmacotherapies Into Medical Practice

This manual provides clinical practice guidelines for using medications in the medication-assisted treatment of alcohol use disorder. It offers guidance on prescribing acamprosate, disulfiram, oral naltrexone, and extended-release injectable naltrexone. The manual also discusses patient management. Access the literature review.

Talking with Your Adult Patients about Alcohol, Drug, and/or Mental Health Problems

This guide provides clinicians with questions to begin discussions with adult patients about mental illness, substance use disorders, or both. It includes resources for patients who need an evaluation after a positive screening.

TAP 32: Clinical Drug Testing in Primary Care

This manual offers guidance to clinicians on implementing drug testing in their practice. It presents the mechanics of testing and outlines steps for preparing staff.

TIP 24: A Guide to Substance Abuse Services for Primary Care Clinicians

This document gives primary care clinicians specific guidance on identifying indications of substance abuse, how to broach the subject with a patient, and what screening and assessment instruments to use. It explains how to perform an office-based brief intervention in which patient and clinician set mutually agreed-upon goals and "contract" to stop or cut back the alcohol or other drug use.